Amarin Corp Plc (AMRN)

[marzan]

Amarin should have got NCE based on the then policy: EPA as the active moiety and for Lovaza the entire mixture was the active moiety then. FDA is playing games interpreting EPA was part of the mixture and so NME for Vascepa. If Amarin applies for NCE now, it will get NCE now based on the current policy. So, don't you think the Judge wonders what is wrong with FDA here.